Nichols DE
Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365, USA.
ArticlePsilocybin
The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.
ArticlePsilocybin
5-HT<sub>2A</sub> receptors: Pharmacology and functional selectivity.
ArticlePsychedelics
The structural diversity of psychedelic drug actions revealed.
ArticleMescaline
History of psychedelic drug science and molecular pharmacology.
ArticlePsilocybin
Chemistry/structural biology of psychedelic drugs and their receptor(s).
ArticlePsychedelics
If Everything Is Psychedelic, Then Nothing Is: A Response to O'Donnell et al. and Lepow et al.
ArticlePsychedelics
Proposed Consensus Statement on Defining Psychedelic Drugs.
ArticleLSD
Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.
ArticleMDMA
Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated.
ArticleLSD
The History of Psychedelics in Psychiatry.
ArticlePsilocybin
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT<sub>2A</sub> Serotonin Receptor.
ArticlePsilocybin
Psilocybin: from ancient magic to modern medicine.
ArticlePsilocybin
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
ArticleLSD
Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
ArticleLSD
Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
ArticlePsilocybin
Psychedelic Drugs in Biomedicine.
ArticleLSD
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
ArticlePsilocybin
Psychedelics.
ArticleDMT